Related Experiment Video
Updated: Jul 21, 2026
Measurement of T Cell Alloreactivity Using Imaging Flow Cytometry
Published on: April 19, 2017
The XIIIth Banff Conference on Allograft Pathology: The Banff 2015 Heart Meeting Report: Improving Antibody-Mediated
P Bruneval1, A Angelini2, D Miller3
1Paris Translational Research Center for Organ Transplantation & Department of Pathology, Hôpital Européen Georges Pompidou, Université Paris Descartes Médecine, Paris, France.
Insights
This conference summary highlights challenges in diagnosing heart transplant rejection, focusing on antibody-mediated rejection (AMR) and small vessel arteriopathy. Future research aims to improve diagnostic systems using molecular approaches.
Area of Science:
- Cardiology
- Transplantation Immunology
- Pathology
Background:
- The 13th Banff Conference addressed critical diagnostic challenges in heart transplantation.
- Key focus areas included antibody-mediated rejection (AMR) and small vessel arteriopathy.
Purpose of the Study:
- To summarize discussions on current diagnostic issues in heart allograft pathology.
- To explore the role of AMR in cardiac allograft vasculopathy and serologic antibody detection.
- To consider new molecular approaches for improving diagnostic systems.
Main Methods:
- The cardiac session featured presentations and multidisciplinary discussions.
- Key topics included limitations of current rejection grading systems.
- Semiquantitative assessment of histopathologic and immunophenotypic indicators was discussed.
Main Results:
- Microvascular injury plays a central role in AMR.
- AMR is implicated in the development of cardiac allograft vasculopathy.
- Serologic antibody detection is crucial for managing transplant recipients.
Conclusions:
- Current diagnostic systems for heart transplant rejection have limitations.
- New molecular approaches may enhance understanding and diagnosis of AMR.
- Multidisciplinary collaboration is essential for advancing allograft pathology diagnostics.
Abstract:
The 13th Banff Conference on Allograft Pathology was held in Vancouver, British Columbia, Canada from October 5 to 10, 2015. The cardiac session was devoted to current diagnostic issues in heart transplantation with a focus on antibody-mediated rejection (AMR) and small vessel arteriopathy. Specific topics included the strengths and limitations of the current rejection grading system, the central role of microvascular injury in AMR and approaches to semiquantitative assessment of histopathologic and immunophenotypic indicators, the role of AMR in the development of cardiac allograft vasculopathy, the important role of serologic antibody detection in the management of transplant recipients, and the potential application of new molecular approaches to the elucidation of the pathophysiology of AMR and potential for improving the current diagnostic system. Herein we summarize the key points from the presentations, the comprehensive, open and wide-ranging multidisciplinary discussion that was generated, and considerations for future endeavors.
